- Home
- KRYS vs FROG Comparison
KRYS vs FROG Comparison
Compare KRYS & FROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- FROG
- Stock Information
- Founded
- KRYS 2015
- FROG 2008
- Country
- KRYS United States
- FROG United States
- Employees
- KRYS N/A
- FROG N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- FROG Computer Software: Prepackaged Software
- Sector
- KRYS Health Care
- FROG Technology
- Exchange
- KRYS Nasdaq
- FROG Nasdaq
- Market Cap
- KRYS 4.3B
- FROG 3.6B
- IPO Year
- KRYS 2017
- FROG 2020
- Fundamental
- Price
- KRYS $153.22
- FROG $45.14
- Analyst Decision
- KRYS Strong Buy
- FROG Strong Buy
- Analyst Count
- KRYS 11
- FROG 19
- Target Price
- KRYS $204.27
- FROG $41.17
- AVG Volume (30 Days)
- KRYS 273.0K
- FROG 815.0K
- Earning Date
- KRYS 08-04-2025
- FROG 08-07-2025
- Dividend Yield
- KRYS N/A
- FROG N/A
- EPS Growth
- KRYS 109.01
- FROG N/A
- EPS
- KRYS 4.16
- FROG N/A
- Revenue
- KRYS $333,448,000.00
- FROG $450,584,000.00
- Revenue This Year
- KRYS $40.10
- FROG $19.77
- Revenue Next Year
- KRYS $49.73
- FROG $15.14
- P/E Ratio
- KRYS $36.72
- FROG N/A
- Revenue Growth
- KRYS 247.53
- FROG 21.66
- 52 Week Low
- KRYS $122.80
- FROG $22.91
- 52 Week High
- KRYS $212.06
- FROG $45.36
- Technical
- Relative Strength Index (RSI)
- KRYS 60.29
- FROG 68.43
- Support Level
- KRYS $147.35
- FROG $40.94
- Resistance Level
- KRYS $154.99
- FROG $42.84
- Average True Range (ATR)
- KRYS 4.27
- FROG 1.21
- MACD
- KRYS 0.11
- FROG 0.33
- Stochastic Oscillator
- KRYS 69.85
- FROG 94.42
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About FROG JFrog Ltd.
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from Israel and also has its presence in United States, India and other regions.